Evidence map›Paper›PMID 28456935›Full record

ReviewMolecular neurobiology2018

PROneurotrophins and CONSequences.

Rui O Costa, Tânia Perestrelo, Ramiro D Almeida

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Biomarkers of Depression among Adolescent Girls: BDNF and Epigenetics.International journal of molecular sciences · 2024
    Article
  5. The intriguing role of platelets as custodians of brain-derived neurotrophic factor.Research and practice in thrombosis and haemostasis · 2024
    Article
  6. Article
  7. Neurotrophins: Neuroimmune Interactions in Human Atopic Diseases.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Chronic Treatment With 5-HTNeurochemical research · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rui O CostaCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal. ruiocosta@gmail.com.
Tânia PerestreloCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
Ramiro D AlmeidaCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal. ramirodalmeida@gmail.com.
University of Coimbra · PT

Funding

FEDER through the Operational Programme Competitiveness Factors - COMPETE - and by national funds through Foundation for Science and Technology (FCT) EXPL/NEU-NMC/0541/2012FEDER through the Operational Programme Competitiveness Factors - COMPETE - and by national funds through Foundation for Science and Technology (FCT) PTDC/SAU-NEU/104100/2008FEDER through the Operational Programme Competitiveness Factors - COMPETE - and by national funds through Foundation for Science and Technology (FCT) UID/NEU/04539/2013Foundation for Science and Technology (FCT) SFRH/BD/51684/2011Foundation for Science and Technology (FCT) SFRH/BPD/84593/2012
6 · The paper itself

Abstract

Proneurotrophins were initially thought to be simple inactive precursors, only responsible for promoting the folding of the mature domain and for the regulation of the neurotrophin secretory pathway. However, recent evidence shows that proneurotrophins can be secreted to the extracellular space, bind with high affinity to specific receptor complexes and induce activation of the apoptotic machinery with subsequent cell death of different neuronal populations. These pathways can be activated due to injury and to several neurodegenerative disorders, which promote proneurotrophin secretion to the extracellular space. In addition to neuropathology, extracellular proneurotrophins also play a pivotal role in many other cellular mechanisms in the nervous system. Proneurotrophins were shown to mediate synaptic plasticity, namely long-term depression in hippocampal neurons. They are also important in axonal development, and an increase of pro- to mature neurotrophin ratio has been described as a trigger of cell death. The conversion of proneurotrophins into the respective mature form is controlled by the action of several enzymes and regulators. The failure in this regulation is now considered one of the possible mechanisms responsible for pathological cell death associated to proneurotrophins. Here, we discuss the processes behind proneurotrophin action, with particular focus on proBDNF and proNGF and their regulatory pathways. Additionally, we review the most recent studies concerning proneurotrophin involvement in neuronal death, in several disease-associated states in the CNS and PNS, and discuss future avenues of investigation in the proneurotrophin field.

Indexed as

AnimalsBehaviorHumansNerve Growth FactorsNervous System DiseasesNeurogenesisProtein PrecursorsSynapsesNerve Growth FactorsProtein PrecursorsDiseaseNeuronal cell deathProBDNFProneurotrophinsProNGF

Identifiers

PMID28456935
OpenAlexW2607890238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.